A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer
Cao, Lu, Xiang, Guomin, Liu, Fang, Xu, Cong, Liu, Jing, Meng, Qingxiang, Lyu, Shuhua, Wang, Shuling, Niu, YunJournal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-019-03891-6
Date:
July, 2019
File:
PDF, 6.16 MB
2019